Space may be the final frontier, but to boldly go where no one has gone before will require the development of new technology that allows humans to travel farther into deep space. One such technology may be bioprinting, given its potential to 3D print critical tissues for treatment in a place that’s far from any hospital.

To begin bioprinting efforts in space, two well-established companies, Techshot and nScrypt, have partnered to create the 3D BioFabrication Facility (BFF), which is set to make a journey to the International Space Station (ISS) in February 2019. To learn more about the technology and the upcoming mission, engineering.com spoke to nScrypt CEO Ken Church and Rich Boling, vice president of Corporate Advancement at Techshot.